Kuva Labs to Acquire Lisata Therapeutics in a $21.38 Million Deal
Lisata Therapeutics, Inc. (LSTA) entered a merger agreement on March 6, 2026, to be acquired by Kuva Labs Inc. in a deal valued at $21.38 million. Deal Structure: Kuva will…
Written byAsif SuriaSource: InsideArbitrage
Lisata Therapeutics, Inc. (LSTA) entered a merger agreement on March 6, 2026, to be acquired by Kuva Labs Inc. in a deal valued at $21.38 million. Deal Structure: Kuva will commence a tender offer to acquire all the issued and outstanding shares of common stock of Lisata for $5 per share in cash plus one